BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11146039)

  • 1. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.
    Mankoff DA; Bellon JR
    Semin Radiat Oncol; 2001 Jan; 11(1):16-27. PubMed ID: 11146039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic
    Montilla-Soler JL; Makanji RJ; Barron BJ
    Am J Med; 2018 Apr; 131(4):357-364. PubMed ID: 29274757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
    Shen B; Huang T; Sun Y; Jin Z; Li XF
    Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in metabolic imaging for surgical oncology.
    Iagaru A; Quon A
    Surg Oncol Clin N Am; 2007 Apr; 16(2):273-92. PubMed ID: 17560512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Present status of PET images: clinical FDG PET in oncology].
    Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential.
    Mercer JR
    J Pharm Pharm Sci; 2007; 10(2):180-202. PubMed ID: 17706177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
    Kubota K
    Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-Fluorodeoxyglucose imaging in oncology.
    Harolds JA
    J Okla State Med Assoc; 1999 Sep; 92(9):457-61. PubMed ID: 10504797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of 18F-FDG positron emission tomography in surgical evaluation].
    Franzius C; Sciuk J; Schober O
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():261-9. PubMed ID: 9931622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical applications of positron emission tomography-computed tomography in oncology.
    Kumar R; Halanaik D; Malhotra A
    Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging in oncology.
    Bar-Shalom R; Valdivia AY; Blaufox MD
    Semin Nucl Med; 2000 Jul; 30(3):150-85. PubMed ID: 10928381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of positron emission tomography (PET) in oncology.
    Weber WA; Avril N; Schwaiger M
    Strahlenther Onkol; 1999 Aug; 175(8):356-73. PubMed ID: 10481766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical role of FDG PET in evaluation of cancer patients.
    Kostakoglu L; Agress H; Goldsmith SJ
    Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of positron emission tomography in oncology.
    Glaspy JA; Hawkins R; Hoh CK; Phelps ME
    Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography imaging in evaluation of cancer patients.
    Kumar R; Bhargava P; Bozkurt MF; Zhuang H; Potenta S; Alavi A
    Indian J Cancer; 2003; 40(3):87-100. PubMed ID: 14716112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.